Investors

Newsol PD GmbH is developing a specialized platform for the GMP-compliant production of dialysis and infusion solutions in Europe.

The company addresses a structurally growing market driven by increasing demand for peritoneal dialysis, the expansion of home-based therapies, and the ongoing outsourcing of pharmaceutical manufacturing.

Newsol PD combines manufacturing, development, and regulatory expertise to support pharmaceutical and medical technology partners in bringing dialysis-related products to market.

The company follows a structured development approach with a focus on:

• Building scalable GMP production capacities
• Developing an integrated CDMO platform
• Establishing a long-term position in the European healthcare sector

Supported by strong partners

Newsol PD collaborates with institutional partners and funding organizations to support the development of its production capacities and the company’s long-term growth.